Regenerative medicine is the utilization of different treatments that can assist the bodies own healing mechanisms.
Regenerative medicine is a new and promising field. Our physicians have years of experience with PRP and regenerative injections, and strives to stay on top of the latest research and science. Dr. Sussman has been involved in publishing book chapters and peer-reviewed research on platelet rich plasma and autologous stem cell procedures.
The FDA has provided guidelines regarding the use of human cells, tissues, and cellular or tissue-based products. At Boston Sports & Biologics, we recognize the FDA's important role in protecting patients and assuring safety. The FDA has not approved any orthobiologic or regenerative procedure, but certain systems have received FDA-clearance. All of our treatment protocol are compliant with published FDA-guidelines and with FDA-cleared system.
At Boston Sports & Biologics our practice is centered around the use of orthobiologics for orthopedic indications, including procedures to manage knee arthritis, meniscus tears, tendon & ligament tears, overuse injuries and other conditions.
The body’s natural reaction to an injury is to send platelets from the blood to the damaged tissues to initiate healing. PRP is a less invasive method of injury management and a faster means of returning to activity. Platelets store growth factors help with healing, and when injected directly into injured tissue they stimulate and enhance the body’s own healing response. A blood sample is obtained from the patient, and a concentration of platelets and growth factors are separated and then injected into the injured area.
Mesenchymal Stem Cells (MSCs) are a special type of cell that can differentiate into different types of cells depending on the signals they receive from surrounding tissues. These cells have also been referred to as Medicinal Signaling Cells to more accurately reflect the fact that these cells secrete bioactive signals to stimulate resident stem cells to construct new tissue (Arnold Caplan. Stem Cells Translational Medicine 2017). MSC have been used in orthopedics for more than 2 decades. Studies have shown benefit with both bone marrow derived stem cells (BMAC) and adipose-derived MSCs (Zhao et al. Arthroscopy 2021).
Lipogems is a minimally invasive procedure used ot harvest, concentrate and transfer a patients own fat for the repair, reconstruction, and replacement of injured or damaged tissue. Adipose tissue, commonly known as fat, has many natural reparative characteristics that help to promote a healing environment throughout the body. Lipogems is a FDA-cleared system for orthopedic use, and procedures proctocol are compliant with FDA guidance.
Like all medical procedures, regenerative procedures have a success and failure rate. Not all patients will experience the same results, and results may vary based on an individual’s overall condition, severity of the pathology and recovery time.